AngioSoma (OTCQB:SOAN) said today that it named Ken Stephenson to the Montgomery, Texas-based company’s corner office. Alexanderia Blankenship will now serve as chief operating officer and executive VP. Stephenson has worked with hospitals, health insurance organizations and physician’s offices throughout Texas, according to the company. He previously helped set up practices for interventional radiologists and […]
AngioSoma
AngioSoma taps La Jolla Capital for Liprostin JV
AngioSoma (OTCQB:SOAN) said today that it landed a joint venture with La Jolla Capital to help fund and manage phase III trials studying its flagship product, Liprostin. The Montgomery, Texas-based company has completed 1 phase I and 3 phase II clinical trials evaluating its lead pharmaceutical candidate. Liprostin is a liposomal encapsulated prostaglandin, developed to […]